ECONOMIC EVALUATION OF ANIDULAFUNGIN FOR CANDIDEMIA OR INVASIVE CANDIDIASIS THERAPY IN KOREA

被引：0
|
作者：
Kim, H. J. [1 ]
Oh, J. J. [1 ]
Park, H. J. [1 ]
Ko, S. K. [1 ]
机构：
[1] Pfizer Pharmaceut Korea Ltd, Seoul, South Korea
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 04期
关键词：
D O I：
10.1016/j.jval.2012.03.1314
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A244 / A244
页数：1
相关论文
共 50 条
  • [31] COST-EFFECTIVENESS OF ANIDULAFUNGIN FOR THE TREATMENT OF INVASIVE CANDIDIASIS IN COLOMBIA
    Diaz, J. A.
    Urrego-Novoa, J. R.
    Moreno, J. A.
    Huerfano, C.
    Prieto, V. A.
    VALUE IN HEALTH, 2015, 18 (03) : A238 - A238
  • [32] Candidemia and invasive candidiasis in the adult: Clinical forms and treatment
    Cervera, Carlos
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2012, 30 (08): : 483 - 491
  • [33] Existing and emerging therapies for the treatment of invasive candidiasis and candidemia
    De Bels, David
    Maillart, Evelyne
    Van Bambeke, Francoise
    Redant, Sebastien
    Honore, Patrick M.
    EXPERT OPINION ON EMERGING DRUGS, 2022, 27 (04) : 405 - 416
  • [34] Candidemia and invasive candidiasis: A review of the literature for the burns surgeon
    Ha, Jennifer F.
    Italiano, Claire M.
    Heath, Christopher H.
    Shih, Sophia
    Rea, Suzanne
    Wood, Fiona M.
    BURNS, 2011, 37 (02) : 181 - 195
  • [35] Recent Advances in the Management of Invasive Candidiasis Role of Anidulafungin FOREWORD
    Viscoli, Claudio
    DRUGS, 2009, 69 : 1 - 3
  • [36] PHARMACOKINETICS OF MICAFUNGIN IN PEDIATRIC PATIENTS WITH INVASIVE CANDIDIASIS AND CANDIDEMIA
    Undre, Nasrullah A.
    Stevenson, Paul
    Freire, Antonio
    Arrieta, Antonio
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (06) : 630 - 632
  • [37] Pharmacokinetics of micafungin in pediatric patients with invasive candidiasis and candidemia
    Freire, Antonio
    Arrieta, Antonio
    Undre, Nas
    Stevenson, Paul
    CRITICAL CARE MEDICINE, 2007, 35 (12) : A111 - A111
  • [38] Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome
    Reboli, Annette C.
    Shorr, Andrew F.
    Rotstein, Coleman
    Pappas, Peter G.
    Kett, Daniel H.
    Schlamm, Haran T.
    Reisman, Arlene L.
    Biswas, Pinaki
    Walsh, Thomas J.
    BMC INFECTIOUS DISEASES, 2011, 11
  • [39] Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome
    Annette C Reboli
    Andrew F Shorr
    Coleman Rotstein
    Peter G Pappas
    Daniel H Kett
    Haran T Schlamm
    Arlene L Reisman
    Pinaki Biswas
    Thomas J Walsh
    BMC Infectious Diseases, 11
  • [40] Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients
    Ruhnke, M.
    Paiva, J. A.
    Meersseman, W.
    Pachl, J.
    Grigoras, I.
    Sganga, G.
    Menichetti, F.
    Montravers, P.
    Auzinger, G.
    Dimopoulos, G.
    Borges Sa, M.
    Miller, P. J.
    Marcek, T.
    Kantecki, M.
    CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 (07) : 680 - 687
12345